Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway.
Crohn's disease is a common, chronic inflammatory bowel condition characterized by remission and relapse. Accumulating evidence indicates that activated T cells play an important role in this disease. In the present study, we aimed to examine the effect of beauvericin, a natural cyclic peptide,...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3858350?pdf=render |
| _version_ | 1811233607784595456 |
|---|---|
| author | Xue-Feng Wu Rui Xu Zi-Jun Ouyang Cheng Qian Yan Shen Xu-Dong Wu Yan-Hong Gu Qiang Xu Yang Sun |
| author_facet | Xue-Feng Wu Rui Xu Zi-Jun Ouyang Cheng Qian Yan Shen Xu-Dong Wu Yan-Hong Gu Qiang Xu Yang Sun |
| author_sort | Xue-Feng Wu |
| collection | DOAJ |
| description | Crohn's disease is a common, chronic inflammatory bowel condition characterized by remission and relapse. Accumulating evidence indicates that activated T cells play an important role in this disease. In the present study, we aimed to examine the effect of beauvericin, a natural cyclic peptide, on 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice, which mimics Crohn's disease. Beauvericin significantly reduced weight loss, diarrhea and mortality, accompanied with notable alleviation of macroscopic and microscopic signs. In addition, this compound decreased serum levels of tumor necrosis factor (TNF)-α and interferon (IFN)-γ in a concentration-dependent manner in mice with experimental colitis. These effects of beauvericin are attributed to its inhibition on activated T cells. Flow cytometry and immunoblot assay data showed that beauvericin suppressed T-cell proliferation, activation and IFN-γ-STAT1-T-bet signaling and subsequently led to apoptosis of activated T cells by suppressing Bcl-2 and phosphorylated Bad as well as increasing cleavage of caspase-3, -9, -12 and PARP. Furthermore, inhibition of PI3K/Akt signaling, which was an upstream regulator of cell activation and survival in activated T cells, contributed to the effect of beauvericin. Overall, these results supported beauvericin as a novel drug candidate for the treatment of colonic inflammation mainly by targeting PI3K/Akt in activated T cells. |
| first_indexed | 2024-04-12T11:22:38Z |
| format | Article |
| id | doaj.art-e0cff9a083974fad9d222eb5d5234172 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T11:22:38Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-e0cff9a083974fad9d222eb5d52341722022-12-22T03:35:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e8301310.1371/journal.pone.0083013Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway.Xue-Feng WuRui XuZi-Jun OuyangCheng QianYan ShenXu-Dong WuYan-Hong GuQiang XuYang SunCrohn's disease is a common, chronic inflammatory bowel condition characterized by remission and relapse. Accumulating evidence indicates that activated T cells play an important role in this disease. In the present study, we aimed to examine the effect of beauvericin, a natural cyclic peptide, on 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice, which mimics Crohn's disease. Beauvericin significantly reduced weight loss, diarrhea and mortality, accompanied with notable alleviation of macroscopic and microscopic signs. In addition, this compound decreased serum levels of tumor necrosis factor (TNF)-α and interferon (IFN)-γ in a concentration-dependent manner in mice with experimental colitis. These effects of beauvericin are attributed to its inhibition on activated T cells. Flow cytometry and immunoblot assay data showed that beauvericin suppressed T-cell proliferation, activation and IFN-γ-STAT1-T-bet signaling and subsequently led to apoptosis of activated T cells by suppressing Bcl-2 and phosphorylated Bad as well as increasing cleavage of caspase-3, -9, -12 and PARP. Furthermore, inhibition of PI3K/Akt signaling, which was an upstream regulator of cell activation and survival in activated T cells, contributed to the effect of beauvericin. Overall, these results supported beauvericin as a novel drug candidate for the treatment of colonic inflammation mainly by targeting PI3K/Akt in activated T cells.http://europepmc.org/articles/PMC3858350?pdf=render |
| spellingShingle | Xue-Feng Wu Rui Xu Zi-Jun Ouyang Cheng Qian Yan Shen Xu-Dong Wu Yan-Hong Gu Qiang Xu Yang Sun Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway. PLoS ONE |
| title | Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway. |
| title_full | Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway. |
| title_fullStr | Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway. |
| title_full_unstemmed | Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway. |
| title_short | Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway. |
| title_sort | beauvericin ameliorates experimental colitis by inhibiting activated t cells via downregulation of the pi3k akt signaling pathway |
| url | http://europepmc.org/articles/PMC3858350?pdf=render |
| work_keys_str_mv | AT xuefengwu beauvericinamelioratesexperimentalcolitisbyinhibitingactivatedtcellsviadownregulationofthepi3kaktsignalingpathway AT ruixu beauvericinamelioratesexperimentalcolitisbyinhibitingactivatedtcellsviadownregulationofthepi3kaktsignalingpathway AT zijunouyang beauvericinamelioratesexperimentalcolitisbyinhibitingactivatedtcellsviadownregulationofthepi3kaktsignalingpathway AT chengqian beauvericinamelioratesexperimentalcolitisbyinhibitingactivatedtcellsviadownregulationofthepi3kaktsignalingpathway AT yanshen beauvericinamelioratesexperimentalcolitisbyinhibitingactivatedtcellsviadownregulationofthepi3kaktsignalingpathway AT xudongwu beauvericinamelioratesexperimentalcolitisbyinhibitingactivatedtcellsviadownregulationofthepi3kaktsignalingpathway AT yanhonggu beauvericinamelioratesexperimentalcolitisbyinhibitingactivatedtcellsviadownregulationofthepi3kaktsignalingpathway AT qiangxu beauvericinamelioratesexperimentalcolitisbyinhibitingactivatedtcellsviadownregulationofthepi3kaktsignalingpathway AT yangsun beauvericinamelioratesexperimentalcolitisbyinhibitingactivatedtcellsviadownregulationofthepi3kaktsignalingpathway |